$MRK Company News 4 more ‘Amazon’ stocks y
Post# of 44843
Posted On: 10/28/2014 10:42:16 AM
$MRK Company News
4 more ‘Amazon’ stocks you may want to avoid 8:43 p.m. Oct. 27, 2014 - Philip van Doorn
Twitter shares drop in wake of quarterly results 5:07 p.m. Oct. 27, 2014 - Sue Chang
Energy stocks sap S&P 500 4:22 p.m. Oct. 27, 2014 - Barbara Kollmeyer
Newscast: The fall ratings race is underway 9:58 a.m. Oct. 27, 2014 - MarketWatch
‘Monsters under the bed’ threaten market’s seasonal boost 9:09 a.m. Oct. 27, 2014 - Shawn Langlois
4 warnings for companies after Amazon’s spectacular loss 8:30 a.m. Oct. 27, 2014 - Marek Fuchs
Merck tightens guidance as sales hit by generics 7:17 a.m. Oct. 27, 2014 - MarketWatch.com
Merck's stock gains 0.7% in premarket trade 7:10 a.m. Oct. 27, 2014 - Tomi Kilgore
Merck 2014 revises adj. EPS outlook to $3.46-$3.50 from $3.43-$3.53 7:07 a.m. Oct. 27, 2014 - Tomi Kilgore
Merck Q3 sales $10.56 bln vs. $11.03 bln; FactSet consensus $10.65 bln 7:07 a.m. Oct. 27, 2014 - Tomi Kilgore
Merck Q3 net EPS 31 cents vs. 38 cents a year ago 7:06 a.m. Oct. 27, 2014 - Tomi Kilgore
Merck Q3 adj. EPS 90 cents vs. FactSet consensus 88 cents 7:06 a.m. Oct. 27, 2014 - Tomi Kilgore
Energy, health care earnings to dominate week 5:02 a.m. Oct. 26, 2014 - Wallace Witkowski
At the NYSE, Larry Kofsky previews the week ahead 11:15 a.m. Oct. 25, 2014 - MarketWatch
Blame the Fed for the coming wealth destruction 4:53 p.m. Oct. 16, 2014 - The Trading Deck
Ebola vaccine use likely to be confined, experts say 7:27 a.m. Oct. 8, 2014 - Russ Britt
Esperion shares rally on cholesterol drug study 6:03 p.m. Oct. 1, 2014 - Wallace Witkowski
The ominous volatility burst and a trend to consider when picking those shorts 9:06 a.m. Sept. 30, 2014 - Shawn Langlois
Indian Prime Minister courts U.S. CEOs 4:19 p.m. Sept. 29, 2014 - Sital S. Patel
Copycat technology is the next big thing 8:51 a.m. Sept. 29, 2014 - Marek Fuchs
Novartis Boosted by Stake Sale 5:55 a.m. Today - The Wall Street Journal Interactive Edition
Quality Plays 10:47 p.m. Oct. 27, 2014 - Seeking Alpha
Reward No Longer Outweighs Risk in Utilities 8:30 p.m. Oct. 27, 2014 - InvestorPlace.com
Are XLV And The Health Care Sector Overpriced? 6:09 p.m. Oct. 27, 2014 - Seeking Alpha
Merck's (MRK) CEO Ken Frazier on Q3 2014 Results - Earnings Call Transcript 4:55 p.m. Oct. 27, 2014 - Seeking Alpha
Stock Market Today: U.S. Stocks Continue to Party as Oil Nears $70s 4:25 p.m. Oct. 27, 2014 - TheStreet.com
The 4 DJIA Stocks That Guided Markets to a Mixed Close 3:21 p.m. Oct. 27, 2014 - 247WallSt.com
Stock Market Today: Oil Drives Stocks Lower as Goldman Sees Crude at $74 a Barrel 3:03 p.m. Oct. 27, 2014 - TheStreet.com
Can U.S. Stocks Go Higher if Oil Prices Keep Going Lower? 2:56 p.m. Oct. 27, 2014 - TheStreet.com
Gilead Rises Ahead Of Q3 Earnings As Rivals Wobble 2:38 p.m. Oct. 27, 2014 - Investors Business Daily
Merck Conference Call Highlights 2:34 p.m. Oct. 27, 2014 - benzinga.com
3 Drugs Stocks Dragging The Industry Down 1:20 p.m. Oct. 27, 2014 - TheStreet.com
Dow Jones (DJIA) Today: Merck (MRK) Lower 1:00 p.m. Oct. 27, 2014 - TheStreet.com
Merck (MRK) Earnings Report: Q3 2014 Conference Call Transcript 12:19 p.m. Oct. 27, 2014 - TheStreet.com
Stock Market Today: Energy Tumbles on Goldman Downgrade, Pending Home Sales Disappoint 11:21 a.m. Oct. 27, 2014 - TheStreet.com
Merck (MRK) Stock Lower After Announcing Third Quarter Earnings Results 11:03 a.m. Oct. 27, 2014 - TheStreet.com
Merck Tops on Q3 Earnings, Patent Expiries Hit Revenues - Analyst Blog 11:00 a.m. Oct. 27, 2014 - Zacks.com
The Dow 30 Stocks: Market-Maker Forecasts Of Their Key Attributes 10:40 a.m. Oct. 27, 2014 - Seeking Alpha
Stock Market News for October 27, 2014 - Market News 10:10 a.m. Oct. 27, 2014 - Zacks.com
Guidance Remains on Weak Side - Ahead of Wall Street 9:49 a.m. Oct. 27, 2014 - Zacks.com
Time Magazine Warns Against Investing In Certain "Ebola Stocks" 9:22 a.m. Today - ACCESSWIRE
Clarus Ventures Adds Barry Gertz, M.D., Ph.D., and Ari Brettman, M.D., to Cambridge Office 8:05 a.m. Oct. 27, 2014 - PR Newswire - PRF
Merck Receives FDA Breakthrough Therapy Designation for KEYTRUDA® (pembrolizumab) in Advanced Non-Small Cell Lung Cancer 6:45 a.m. Oct. 27, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Brower Piven Announces Class Action Lawsuit In Connection With The Sale Of Sigma-Aldrich Corporation 3:30 p.m. Oct. 22, 2014 - BusinessWire - BZX
DiversityInc Presents Special Awards Honoring Extraordinary Companies for Diversity Management 6:30 a.m. Oct. 22, 2014 - PR Newswire - PRF
Merger Deal Updates, Dividend, Dispute Settlement, Regulatory Application Submission, and Preliminary Results - Research Reports on Shire, Johnson & Johnson, Merck, Amgen and HCA 9:00 a.m. Oct. 21, 2014 - PR Newswire - PRF
Phlexglobal Announces Key Industry Appointment 11:34 a.m. Oct. 20, 2014 - BusinessWire - BZX
Sascha Becker Will Join Grünenthal Group as new CFO 8:51 a.m. Oct. 20, 2014 - PR Newswire - PRF
US FDA Accepts for Review a Biologics License Application for Merck and Sanofi Pasteur’s Investigational Pediatric Hexavalent Vaccine 8:02 a.m. Oct. 20, 2014 - BusinessWire - BZX
Award-Winning Actress S. Epatha Merkerson and Merck Challenge African Americans with Type 2 Diabetes to Get to Their Goals 8:00 a.m. Oct. 20, 2014 - PR Newswire - PRF
Advaxis Appoints David J. Mauro, M.D., Ph.D., as Chief Medical Officer 7:30 a.m. Oct. 20, 2014 - GlobeNewswire
LitCoat Takes Paint To A New Level With Electroluminescence 12:14 p.m. Oct. 17, 2014 - PR Newswire - PRF
BIO-Europe® 2014 Program is Abundant Showcase of Life Science Pharma Executives and Thought Leaders 6:00 a.m. Oct. 16, 2014 - BusinessWire - BZX
Merck Announces Final Results of Tender Offers for Eight Series of Notes 8:03 a.m. Oct. 15, 2014 - BusinessWire - BZX
Merck Announces Pricing of Tender Offers for Eight Series of Notes 6:20 p.m. Oct. 14, 2014 - BusinessWire - BZX
North America Pharmaceutical Packaging Market - By Primary Packaging Material, Type Of Packaging, Geography And Vendors - Forecasts, Trends And Shares (2014- 2019) 6:21 p.m. Oct. 13, 2014 - PR Newswire - PRF
Welfare Initiatives, Clinical Data Presentation, Financing Plan, Regulatory Disclosure, and Positive Drug Trials - Research Reports on Johnson & Johnson, Merck, Medtronic, Covidien and Amgen 8:35 a.m. Oct. 13, 2014 - PR Newswire - PRF
North American Active And Intelligent Packaging Market -By Type, Applications, Geography And Vendors - Forecasts, Trends And Shares (2014- 2019) 5:37 p.m. Oct. 9, 2014 - PR Newswire - PRF
Leading Pharma Companies Help Shape New Accenture Life Sciences Cloud for R&D 10:03 a.m. Oct. 9, 2014 - BusinessWire - BZX
Merck & Co. Executive Pamela Demain Elected President of Licensing Executives Society (U.S.A. and Canada) 7:40 p.m. Oct. 8, 2014 - BusinessWire - BZX
4 more ‘Amazon’ stocks you may want to avoid 8:43 p.m. Oct. 27, 2014 - Philip van Doorn
Twitter shares drop in wake of quarterly results 5:07 p.m. Oct. 27, 2014 - Sue Chang
Energy stocks sap S&P 500 4:22 p.m. Oct. 27, 2014 - Barbara Kollmeyer
Newscast: The fall ratings race is underway 9:58 a.m. Oct. 27, 2014 - MarketWatch
‘Monsters under the bed’ threaten market’s seasonal boost 9:09 a.m. Oct. 27, 2014 - Shawn Langlois
4 warnings for companies after Amazon’s spectacular loss 8:30 a.m. Oct. 27, 2014 - Marek Fuchs
Merck tightens guidance as sales hit by generics 7:17 a.m. Oct. 27, 2014 - MarketWatch.com
Merck's stock gains 0.7% in premarket trade 7:10 a.m. Oct. 27, 2014 - Tomi Kilgore
Merck 2014 revises adj. EPS outlook to $3.46-$3.50 from $3.43-$3.53 7:07 a.m. Oct. 27, 2014 - Tomi Kilgore
Merck Q3 sales $10.56 bln vs. $11.03 bln; FactSet consensus $10.65 bln 7:07 a.m. Oct. 27, 2014 - Tomi Kilgore
Merck Q3 net EPS 31 cents vs. 38 cents a year ago 7:06 a.m. Oct. 27, 2014 - Tomi Kilgore
Merck Q3 adj. EPS 90 cents vs. FactSet consensus 88 cents 7:06 a.m. Oct. 27, 2014 - Tomi Kilgore
Energy, health care earnings to dominate week 5:02 a.m. Oct. 26, 2014 - Wallace Witkowski
At the NYSE, Larry Kofsky previews the week ahead 11:15 a.m. Oct. 25, 2014 - MarketWatch
Blame the Fed for the coming wealth destruction 4:53 p.m. Oct. 16, 2014 - The Trading Deck
Ebola vaccine use likely to be confined, experts say 7:27 a.m. Oct. 8, 2014 - Russ Britt
Esperion shares rally on cholesterol drug study 6:03 p.m. Oct. 1, 2014 - Wallace Witkowski
The ominous volatility burst and a trend to consider when picking those shorts 9:06 a.m. Sept. 30, 2014 - Shawn Langlois
Indian Prime Minister courts U.S. CEOs 4:19 p.m. Sept. 29, 2014 - Sital S. Patel
Copycat technology is the next big thing 8:51 a.m. Sept. 29, 2014 - Marek Fuchs
Novartis Boosted by Stake Sale 5:55 a.m. Today - The Wall Street Journal Interactive Edition
Quality Plays 10:47 p.m. Oct. 27, 2014 - Seeking Alpha
Reward No Longer Outweighs Risk in Utilities 8:30 p.m. Oct. 27, 2014 - InvestorPlace.com
Are XLV And The Health Care Sector Overpriced? 6:09 p.m. Oct. 27, 2014 - Seeking Alpha
Merck's (MRK) CEO Ken Frazier on Q3 2014 Results - Earnings Call Transcript 4:55 p.m. Oct. 27, 2014 - Seeking Alpha
Stock Market Today: U.S. Stocks Continue to Party as Oil Nears $70s 4:25 p.m. Oct. 27, 2014 - TheStreet.com
The 4 DJIA Stocks That Guided Markets to a Mixed Close 3:21 p.m. Oct. 27, 2014 - 247WallSt.com
Stock Market Today: Oil Drives Stocks Lower as Goldman Sees Crude at $74 a Barrel 3:03 p.m. Oct. 27, 2014 - TheStreet.com
Can U.S. Stocks Go Higher if Oil Prices Keep Going Lower? 2:56 p.m. Oct. 27, 2014 - TheStreet.com
Gilead Rises Ahead Of Q3 Earnings As Rivals Wobble 2:38 p.m. Oct. 27, 2014 - Investors Business Daily
Merck Conference Call Highlights 2:34 p.m. Oct. 27, 2014 - benzinga.com
3 Drugs Stocks Dragging The Industry Down 1:20 p.m. Oct. 27, 2014 - TheStreet.com
Dow Jones (DJIA) Today: Merck (MRK) Lower 1:00 p.m. Oct. 27, 2014 - TheStreet.com
Merck (MRK) Earnings Report: Q3 2014 Conference Call Transcript 12:19 p.m. Oct. 27, 2014 - TheStreet.com
Stock Market Today: Energy Tumbles on Goldman Downgrade, Pending Home Sales Disappoint 11:21 a.m. Oct. 27, 2014 - TheStreet.com
Merck (MRK) Stock Lower After Announcing Third Quarter Earnings Results 11:03 a.m. Oct. 27, 2014 - TheStreet.com
Merck Tops on Q3 Earnings, Patent Expiries Hit Revenues - Analyst Blog 11:00 a.m. Oct. 27, 2014 - Zacks.com
The Dow 30 Stocks: Market-Maker Forecasts Of Their Key Attributes 10:40 a.m. Oct. 27, 2014 - Seeking Alpha
Stock Market News for October 27, 2014 - Market News 10:10 a.m. Oct. 27, 2014 - Zacks.com
Guidance Remains on Weak Side - Ahead of Wall Street 9:49 a.m. Oct. 27, 2014 - Zacks.com
Time Magazine Warns Against Investing In Certain "Ebola Stocks" 9:22 a.m. Today - ACCESSWIRE
Clarus Ventures Adds Barry Gertz, M.D., Ph.D., and Ari Brettman, M.D., to Cambridge Office 8:05 a.m. Oct. 27, 2014 - PR Newswire - PRF
Merck Receives FDA Breakthrough Therapy Designation for KEYTRUDA® (pembrolizumab) in Advanced Non-Small Cell Lung Cancer 6:45 a.m. Oct. 27, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Brower Piven Announces Class Action Lawsuit In Connection With The Sale Of Sigma-Aldrich Corporation 3:30 p.m. Oct. 22, 2014 - BusinessWire - BZX
DiversityInc Presents Special Awards Honoring Extraordinary Companies for Diversity Management 6:30 a.m. Oct. 22, 2014 - PR Newswire - PRF
Merger Deal Updates, Dividend, Dispute Settlement, Regulatory Application Submission, and Preliminary Results - Research Reports on Shire, Johnson & Johnson, Merck, Amgen and HCA 9:00 a.m. Oct. 21, 2014 - PR Newswire - PRF
Phlexglobal Announces Key Industry Appointment 11:34 a.m. Oct. 20, 2014 - BusinessWire - BZX
Sascha Becker Will Join Grünenthal Group as new CFO 8:51 a.m. Oct. 20, 2014 - PR Newswire - PRF
US FDA Accepts for Review a Biologics License Application for Merck and Sanofi Pasteur’s Investigational Pediatric Hexavalent Vaccine 8:02 a.m. Oct. 20, 2014 - BusinessWire - BZX
Award-Winning Actress S. Epatha Merkerson and Merck Challenge African Americans with Type 2 Diabetes to Get to Their Goals 8:00 a.m. Oct. 20, 2014 - PR Newswire - PRF
Advaxis Appoints David J. Mauro, M.D., Ph.D., as Chief Medical Officer 7:30 a.m. Oct. 20, 2014 - GlobeNewswire
LitCoat Takes Paint To A New Level With Electroluminescence 12:14 p.m. Oct. 17, 2014 - PR Newswire - PRF
BIO-Europe® 2014 Program is Abundant Showcase of Life Science Pharma Executives and Thought Leaders 6:00 a.m. Oct. 16, 2014 - BusinessWire - BZX
Merck Announces Final Results of Tender Offers for Eight Series of Notes 8:03 a.m. Oct. 15, 2014 - BusinessWire - BZX
Merck Announces Pricing of Tender Offers for Eight Series of Notes 6:20 p.m. Oct. 14, 2014 - BusinessWire - BZX
North America Pharmaceutical Packaging Market - By Primary Packaging Material, Type Of Packaging, Geography And Vendors - Forecasts, Trends And Shares (2014- 2019) 6:21 p.m. Oct. 13, 2014 - PR Newswire - PRF
Welfare Initiatives, Clinical Data Presentation, Financing Plan, Regulatory Disclosure, and Positive Drug Trials - Research Reports on Johnson & Johnson, Merck, Medtronic, Covidien and Amgen 8:35 a.m. Oct. 13, 2014 - PR Newswire - PRF
North American Active And Intelligent Packaging Market -By Type, Applications, Geography And Vendors - Forecasts, Trends And Shares (2014- 2019) 5:37 p.m. Oct. 9, 2014 - PR Newswire - PRF
Leading Pharma Companies Help Shape New Accenture Life Sciences Cloud for R&D 10:03 a.m. Oct. 9, 2014 - BusinessWire - BZX
Merck & Co. Executive Pamela Demain Elected President of Licensing Executives Society (U.S.A. and Canada) 7:40 p.m. Oct. 8, 2014 - BusinessWire - BZX
(0)
(0)Scroll down for more posts ▼